MDLN · earnings call history
Medline Q2 FY26 — Strong Top-Line Growth Offset by Margin Headwinds and Strategic Investments
Read the briefMedline Q1 FY26 — Strong Sales Growth and Strategic Investments
Read the briefMedline Q4 FY25 — Strong Sales Growth and Debt Reduction Post-IPO
Read the briefBrowse all US companies on the earnings-call register.